# CYP19A1

## Overview
CYP19A1 is a gene that encodes the enzyme cytochrome P450 family 19 subfamily A member 1, commonly known as aromatase. Aromatase is a crucial enzyme in the cytochrome P450 superfamily, responsible for the biosynthesis of estrogens from androgens. This enzyme is characterized by its heme-thiolate structure, which is essential for its catalytic function in converting androstenedione and testosterone into estrone and 17β-estradiol, respectively (Goldstone2016Genetic; Simpson2002Aromatase—A). Aromatase is predominantly active in the endoplasmic reticulum of various tissues, including the ovaries, testes, and adipose tissue, where it plays a significant role in local estrogen production (Simpson2002Aromatase—A). The regulation of CYP19A1 expression and activity is complex, involving tissue-specific promoters and post-translational modifications, which are critical for maintaining physiological estrogen levels and ensuring normal reproductive and systemic functions (Hudon2018Profile; Ritacco2019PostTranslational). Variations in the CYP19A1 gene have been linked to several clinical conditions, including hormone-dependent cancers and reproductive disorders, highlighting its importance in both health and disease (Pavithran2021In; Heidarzadehpilehrood2022A).

## Structure
CYP19A1, also known as aromatase, is a member of the cytochrome P450 superfamily and plays a crucial role in estrogen biosynthesis. The enzyme is characterized by a heme-thiolate prosthetic group, which is essential for its catalytic activity (Goldstone2016Genetic). The primary structure of CYP19A1 consists of amino acid sequences that form specific domains, including a heme-binding domain crucial for its function (Hanoux2003Differential).

The secondary structure of CYP19A1 includes alpha-helices and beta-sheets, which contribute to its three-dimensional conformation. This tertiary structure is vital for the enzyme's activity, allowing it to interact with substrates and redox partners effectively (Paço2020Dynamics). Although CYP19A1 typically functions as a monomer, its quaternary structure is less defined (Goldstone2016Genetic).

Post-translational modifications, such as phosphorylation, significantly impact CYP19A1's activity and stability. Phosphorylation at specific residues, including Y361, enhances enzyme activity and electron transfer efficiency (Ghosh2019Phosphorylation; Ritacco2019PostTranslational). Alternative splicing of CYP19A1 can lead to different isoforms, potentially affecting substrate recognition and drug metabolism (Annalora2017Alternative). These structural features and modifications underscore the enzyme's functional diversity and regulatory complexity.

## Function
The CYP19A1 gene encodes the enzyme aromatase, which is crucial for the biosynthesis of estrogens from androgens. Aromatase catalyzes the conversion of androstenedione and testosterone into estrone and 17β-estradiol, respectively, through a series of reactions that require oxygen and NADPH (Simpson2002Aromatase—A; Ghosh2019Phosphorylation). This enzyme is active in the endoplasmic reticulum of cells in various tissues, including the ovaries, testes, placenta, adipose tissue, bone, brain, and vasculature (Simpson2002Aromatase—A; Strauss2012Seminal).

In healthy human cells, aromatase plays a significant role in local estrogen production, which acts in a paracrine or intracrine manner, particularly in extragonadal tissues. This local production is essential for physiological functions such as bone health, reproductive function, and brain activity (Simpson2002Aromatase—A; Strauss2012Seminal). The enzyme's activity is regulated by tissue-specific promoters and is influenced by various factors, including hormones and cytokines, which ensure that estrogen levels are appropriately maintained for normal cellular and organismal functions (Simpson2002Aromatase—A; Hudon2018Profile). Aromatase's role in estrogen synthesis is vital for maintaining reproductive health and preventing conditions associated with estrogen imbalance, such as osteoporosis and certain malignancies (Ghosh2019Phosphorylation).

## Clinical Significance
Mutations and alterations in the CYP19A1 gene, which encodes the aromatase enzyme, have significant clinical implications. Variants in CYP19A1 are associated with several estrogen-dependent conditions, including breast and endometrial cancers. In breast cancer, nonsynonymous single nucleotide polymorphisms (nsSNPs) in CYP19A1 can lead to structural disturbances in the aromatase enzyme, affecting its function and potentially increasing cancer risk (Pavithran2021In). Similarly, common variants in CYP19A1, such as the A alleles of SNPs rs749292 and rs727479, are linked to increased circulating estrogen levels and a heightened risk of endometrial cancer, particularly in postmenopausal women (Setiawan2009Two).

CYP19A1 polymorphisms are also implicated in polycystic ovary syndrome (PCOS) and infertility. These genetic variations can alter aromatase activity, leading to imbalances in estrogen and androgen levels, which are critical factors in PCOS pathogenesis (Heidarzadehpilehrood2022A). Additionally, CYP19A1 expression is linked to colon cancer, where its high expression correlates with poor prognosis and immune evasion, suggesting a role in cancer progression and potential as a therapeutic target (Liu2023Targeting). These findings underscore the gene's importance in various diseases, highlighting its potential as a target for therapeutic interventions.

## Interactions
CYP19A1, also known as aromatase, is involved in the conversion of androgens to estrogens and interacts with the P450 oxidoreductase (POR) protein. This interaction is essential for CYP19A1's catalytic activity, as POR facilitates electron transfer from NADPH to CYP19A1. The interaction between CYP19A1 and POR is mediated through ionic interactions involving specific residues on their surfaces. Variations in the hinge region of POR, such as P284L and P284T, can affect its interactions with CYP19A1, leading to changes in enzymatic activity (Parween2019Differential; Udhane2017Altered).

CYP19A1 also undergoes posttranscriptional regulation involving its mRNA's 3′ untranslated region (3′UTR) in bovine granulosa cells. The 3′UTR forms a complex with proteins, affecting mRNA stability and translation. A specific region of the 3′UTR, spanning nucleotides 926 to 1134, is crucial for this regulation. This RNA-protein complex is specific to granulosa cells and is not found in other tissues, suggesting a cell-type-specific regulatory mechanism (Sahmi2019A). The absence of AU-rich motifs in the 3′UTR suggests that traditional RNA-binding proteins may not be involved, and the potential role of microRNAs is considered, although no specific miRNA binding sites were predicted (Sahmi2019A).


## References


[1. (Goldstone2016Genetic) Jared V. Goldstone, Munirathinam Sundaramoorthy, Bin Zhao, Michael R. Waterman, John J. Stegeman, and David C. Lamb. Genetic and structural analyses of cytochrome p450 hydroxylases in sex hormone biosynthesis: sequential origin and subsequent coevolution. Molecular Phylogenetics and Evolution, 94:676–687, January 2016. URL: http://dx.doi.org/10.1016/j.ympev.2015.09.012, doi:10.1016/j.ympev.2015.09.012. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.ympev.2015.09.012)

2. (Parween2019Differential) Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H. This article has 0 citations.

[3. (Strauss2012Seminal) Leena Strauss, Pia Rantakari, Klara Sjögren, Anu Salminen, Eve Lauren, Jenny Kallio, Pauliina Damdimopoulou, Minna Boström, Peter J. Boström, Pirjo Pakarinen, FuPing Zhang, Paula Kujala, Claes Ohlsson, Sari Mäkelä, and Matti Poutanen. Seminal vesicles and urinary bladder as sites of aromatization of androgens in men, evidenced by a cyp19a1‐driven luciferase reporter mouse and human tissue specimens. The FASEB Journal, 27(4):1342–1350, December 2012. URL: http://dx.doi.org/10.1096/fj.12-219048, doi:10.1096/fj.12-219048. This article has 7 citations.](https://doi.org/10.1096/fj.12-219048)

[4. (Hudon2018Profile) Andrée-Anne Hudon Thibeault, Cathy Vaillancourt, and J. Thomas Sanderson. Profile of cyp19a1 mrna expression and aromatase activity during syncytialization of primary human villous trophoblast cells at term. Biochimie, 148:12–17, May 2018. URL: http://dx.doi.org/10.1016/j.biochi.2018.02.010, doi:10.1016/j.biochi.2018.02.010. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2018.02.010)

[5. (Udhane2017Altered) Sameer S. Udhane, Shaheena Parween, Norio Kagawa, and Amit V. Pandey. Altered cyp19a1 and cyp3a4 activities due to mutations a115v, t142a, q153r and p284l in the human p450 oxidoreductase. Frontiers in Pharmacology, August 2017. URL: http://dx.doi.org/10.3389/fphar.2017.00580, doi:10.3389/fphar.2017.00580. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2017.00580)

[6. (Ritacco2019PostTranslational) Ida Ritacco, Angelo Spinello, Emiliano Ippoliti, and Alessandra Magistrato. Post-translational regulation of cyp450s metabolism as revealed by all-atoms simulations of the aromatase enzyme. Journal of Chemical Information and Modeling, 59(6):2930–2940, April 2019. URL: http://dx.doi.org/10.1021/acs.jcim.9b00157, doi:10.1021/acs.jcim.9b00157. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jcim.9b00157)

[7. (Sahmi2019A) Fatiha Sahmi, Malha Sahmi, Nicolas Gévry, Pramod Sahadevan, Bruce G. Allen, and Christopher A. Price. A putative protein–rna complex regulates posttranscriptional processing of cytochrome p450 aromatase (cyp19a1) in bovine granulosa cells. Molecular Reproduction and Development, 86(12):1901–1908, November 2019. URL: http://dx.doi.org/10.1002/mrd.23289, doi:10.1002/mrd.23289. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/mrd.23289)

[8. (Annalora2017Alternative) Andrew J. Annalora, Craig B. Marcus, and Patrick L. Iversen. Alternative splicing in the cytochrome p450 superfamily expands protein diversity to augment gene function and redirect human drug metabolism. Drug Metabolism and Disposition, 45(4):375–389, February 2017. URL: http://dx.doi.org/10.1124/dmd.116.073254, doi:10.1124/dmd.116.073254. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/dmd.116.073254)

[9. (Paço2020Dynamics) Lorela Paço, Francisco Zarate-Perez, Amanda F. Clouser, William M. Atkins, and John C. Hackett. Dynamics and mechanism of binding of androstenedione to membrane-associated aromatase. Biochemistry, 59(33):2999–3009, August 2020. URL: http://dx.doi.org/10.1021/acs.biochem.0c00460, doi:10.1021/acs.biochem.0c00460. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.biochem.0c00460)

[10. (Simpson2002Aromatase—A) Evan R. Simpson, Colin Clyne, Gary Rubin, Wah Chin Boon, Kirsten Robertson, Kara Britt, Caroline Speed, and Margaret Jones. Aromatase—a brief overview. Annual Review of Physiology, 64(1):93–127, March 2002. URL: http://dx.doi.org/10.1146/annurev.physiol.64.081601.142703, doi:10.1146/annurev.physiol.64.081601.142703. This article has 563 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.physiol.64.081601.142703)

[11. (Liu2023Targeting) Lilong Liu, Min Mo, Xuehan Chen, Dongchen Chao, Yufan Zhang, Xuewei Chen, Yang Wang, Nan Zhang, Nan He, Xi Yuan, Honglei Chen, and Jing Yang. Targeting inhibition of prognosis-related lipid metabolism genes including cyp19a1 enhances immunotherapeutic response in colon cancer. Journal of Experimental &amp; Clinical Cancer Research, April 2023. URL: http://dx.doi.org/10.1186/s13046-023-02647-8, doi:10.1186/s13046-023-02647-8. This article has 13 citations.](https://doi.org/10.1186/s13046-023-02647-8)

[12. (Hanoux2003Differential) Vincent Hanoux, Hélène Bouraïma, Hervé Mittre, Colette Féral, and Annie Benhaïm. Differential regulation of two 3′ end variants of p450 aromatase transcripts and of a new truncated aromatase protein in rabbit preovulatory granulosa cells. Endocrinology, 144(11):4790–4798, November 2003. URL: http://dx.doi.org/10.1210/EN.2003-0260, doi:10.1210/en.2003-0260. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/EN.2003-0260)

[13. (Heidarzadehpilehrood2022A) Roozbeh Heidarzadehpilehrood, Maryam Pirhoushiaran, Rasoul Abdollahzadeh, Malina Binti Osman, Maryam Sakinah, Norshariza Nordin, and Habibah Abdul Hamid. A review on cyp11a1, cyp17a1, and cyp19a1 polymorphism studies: candidate susceptibility genes for polycystic ovary syndrome (pcos) and infertility. Genes, 13(2):302, February 2022. URL: http://dx.doi.org/10.3390/genes13020302, doi:10.3390/genes13020302. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13020302)

[14. (Pavithran2021In) Honey Pavithran and Ranjith Kumavath. In silico analysis of nssnps in cyp19a1 gene affecting breast cancer associated aromatase enzyme. Journal of Genetics, April 2021. URL: http://dx.doi.org/10.1007/s12041-021-01274-6, doi:10.1007/s12041-021-01274-6. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12041-021-01274-6)

[15. (Setiawan2009Two) Veronica Wendy Setiawan, Jennifer A. Doherty, Xiao-ou Shu, Mohammad R. Akbari, Chu Chen, Immaculata De Vivo, Angela DeMichele, Montserrat Garcia-Closas, Marc T. Goodman, Christopher A. Haiman, Susan E. Hankinson, Brian E. Henderson, Pamela L. Horn-Ross, James V. Lacey, Loic Le Marchand, Douglas A. Levine, Xiaolin Liang, Jolanta Lissowska, Galina Lurie, Monica McGrath, Steven A. Narod, Timothy R. Rebbeck, Giske Ursin, Noel S. Weiss, Yong-Bing Xiang, Hannah P. Yang, Wei Zheng, and Sara H. Olson. Two estrogen-related variants in cyp19a1 and endometrial cancer risk: a pooled analysis in the epidemiology of endometrial cancer consortium. Cancer Epidemiology, Biomarkers &amp; Prevention, 18(1):242–247, January 2009. URL: http://dx.doi.org/10.1158/1055-9965.epi-08-0689, doi:10.1158/1055-9965.epi-08-0689. This article has 56 citations.](https://doi.org/10.1158/1055-9965.epi-08-0689)

[16. (Ghosh2019Phosphorylation) Debashis Ghosh, Chinaza Egbuta, Jean E. Kanyo, and TuKiet T. Lam. Phosphorylation of human placental aromatasecyp19a1. Biochemical Journal, 476(21):3313–3331, November 2019. URL: http://dx.doi.org/10.1042/bcj20190633, doi:10.1042/bcj20190633. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bcj20190633)